BackAphria Overview

Aphria Current Cash

Track Aphria's current cash ($210M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Current Cash
$209.73M
↓ 45.46% YoYΔ $-174.83M vs prior year quarter

Peer average

Loading

Aphria Current Cash History

Loading

Aphria vs. peers: Current Cash Comparison

Loading

Aphria Cash Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Aphria (APHA) FAQ

Aphria (APHA) currently reports a current cash of $210M as of February 2021. That compares with $380M in the prior-year period — down 45.5% year over year. Use the charts on this page to explore Aphria's current cash history and peer comparisons.

Aphria's current cash decreased from $380M to $210M — a 45.5% year-over-year decrease (period ending February 2021). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Aphria reported $210M in current cash as of February 2021. That compares with $380M in the prior-year period — down 45.5% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current current cash of $210M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Aphria, and consider following APHA for alerts when major investors trade the stock.

Aphria is classified in the Healthcare sector. On current cash, it currently shows $210M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing APHA with unrelated industries.